InfuSystem Holdings Inc (NYSEAMERICAN:INFU)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $8.25. InfuSystem shares last traded at $8.14, with a volume of 404 shares changing hands.
InfuSystem (NYSEAMERICAN:INFU) last released its quarterly earnings results on Wednesday, November 13th. The medical instruments supplier reported $0.05 earnings per share (EPS) for the quarter. The business had revenue of $21.49 million during the quarter.
Institutional investors have recently added to or reduced their stakes in the stock. AWM Investment Company Inc. raised its holdings in InfuSystem by 9.1% during the 2nd quarter. AWM Investment Company Inc. now owns 1,855,362 shares of the medical instruments supplier’s stock worth $7,978,000 after purchasing an additional 155,092 shares during the last quarter. White Pine Capital LLC raised its holdings in InfuSystem by 23.3% during the 2nd quarter. White Pine Capital LLC now owns 494,670 shares of the medical instruments supplier’s stock worth $2,127,000 after purchasing an additional 93,420 shares during the last quarter. Finally, Gabelli Funds LLC raised its holdings in InfuSystem by 4.3% during the 3rd quarter. Gabelli Funds LLC now owns 360,000 shares of the medical instruments supplier’s stock worth $1,904,000 after purchasing an additional 15,000 shares during the last quarter.
InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Recommended Story: What are the advantages to having securities held in street name?
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.